On June 16, 2020, US News and World Report published an Op Ed co-authored by AFAR expert Nir Barzilai, MD, on why those suffering from age-related chronic diseases are more vulnerable to COVID-19.
Dr. Barzilai proposes both long- and short-term policies officials could implement to protect this vulnerable population, and highlights the ways geroscience research is working to prevent future pandemics, such as through the upcoming AFAR-funded Targeting Aging With Metformin (TAME) Trial.
Dr. Barzilai is AFAR’s Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, and the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
The Op-Ed is co-authored with Paul Irving, chairman of the Milken Institute Center for the Future of Aging and distinguished scholar in residence at the University of Southern California Davis School of Gerontology.
Read the article, “Fight the Coronavirus by Defending the Host,” here.
